Clinical Trial

Evaluation of the Uterine Cavity in Perimenopausal Women.

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2025 (before its estimated May 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Abnormal uterine bleeding (AUB) in perimenopausal women is a common yet poorly defined condition requiring accurate diagnosis. Hysteroscopy is the gold standard for evaluating intrauterine abnormalities, but 3D ultrasonography (3D US) has emerged as a non-invasive alternative.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-15; most recent amendment 2025-05-10.
Trial Details
NCT Number NCT06888414
Lead Sponsor Suez University
Conditions Abnormal Uterine Bleeding, Unspecified
Enrollment 50 participants
Start Date 2025-02-01
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-14